Page last updated: 2024-11-05

ticlopidine and Sickle Cell Trait

ticlopidine has been researched along with Sickle Cell Trait in 1 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Sickle Cell Trait: The condition of being heterozygous for hemoglobin S.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sablayrolles, M1
Wajcman, H1
Castaigne, JP1
Labie, D1

Other Studies

1 other study available for ticlopidine and Sickle Cell Trait

ArticleYear
Membrane expansion as a mechanism explaining the antisickling action of ticlopidine observed in vitro.
    American journal of hematology, 1985, Volume: 18, Issue:2

    Topics: Anemia, Sickle Cell; Antisickling Agents; Densitometry; Erythrocyte Membrane; Humans; Kinetics; Osmo

1985